Comparative analysis of breast and colorectal tumours uncouples loss of DNA methylation in cancer from association with the nuclear periphery by Elizabeth Kerr et al.
MEETING ABSTRACT Open Access
Comparative analysis of breast and colorectal
tumours uncouples loss of DNA methylation
in cancer from association with the nuclear
periphery
Elizabeth Kerr, Richard R Meehan, Wendy A Bickmore, Duncan Sproul*
From Birminghm Cancer Epigenetics Conference; Translational Opportunities
Birmingham, UK. 16 May 2013
The most significant epigenetic alteration found in can-
cer cells is a global loss of DNA methylation. Recent
analyses of cancer methylomes have suggested that
methylation is specifically lost from Lamin-associated
domains (LADs) which are associated with the nuclear
periphery. This suggests that nuclear organisation is a
key influence on epigenetic alterations in cancer but the
relationship between nuclear organisation and demethy-
lation has not been directly investigated.
We have combined analyses of cancer methylomes
with fluorescence in-situ hybridisation (FISH) to deter-
mine how nuclear organisation in normal cells relates to
alterations in DNA methylation levels in cancer.
Our analyses demonstrate that DNA methylation is
lost from different regions of the genome in breast and
colorectal tumours. Surprisingly, we find that the pro-
pensity to become demethylated in cancer is not corre-
lated with localisation to the nuclear periphery in the
corresponding normal cell types. While regions some
breast cancer hypomethylated regions are localised to
the periphery in normal breast epithelial cells, an equal
proportion are found in the nuclear interior.
Our observations decouple hypomethylation in cancer
from a peripheral nuclear localisation and suggest that
association with the nuclear lamina is not mechanisti-
cally involved in the loss of methylation in cancer.
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